Title |
Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States - Volume 23, Number 6—June 2017 - Emerging Infectious Diseases journal - CDC
|
---|---|
Published in |
Emerging Infectious Diseases, June 2017
|
DOI | 10.3201/eid2306.161331 |
Pubmed ID | |
Authors |
Cheryl P. Andam, Colin J. Worby, Ryan Gierke, Lesley McGee, Tamara Pilishvili, William P. Hanage |
Abstract |
Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 40% |
United Kingdom | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 37 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 14% |
Researcher | 5 | 14% |
Student > Ph. D. Student | 5 | 14% |
Student > Bachelor | 4 | 11% |
Student > Postgraduate | 3 | 8% |
Other | 4 | 11% |
Unknown | 11 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 16% |
Immunology and Microbiology | 6 | 16% |
Nursing and Health Professions | 5 | 14% |
Biochemistry, Genetics and Molecular Biology | 3 | 8% |
Agricultural and Biological Sciences | 2 | 5% |
Other | 2 | 5% |
Unknown | 13 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2017.
All research outputs
#2,586,918
of 22,965,074 outputs
Outputs from Emerging Infectious Diseases
#2,624
of 9,109 outputs
Outputs of similar age
#50,089
of 316,439 outputs
Outputs of similar age from Emerging Infectious Diseases
#53
of 118 outputs
Altmetric has tracked 22,965,074 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,109 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.7. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 316,439 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.